These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 17636708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S.
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [Abstract] [Full Text] [Related]

  • 5. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
    Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M.
    Cochrane Database Syst Rev; 2017 May 24; 5(5):CD005070. PubMed ID: 28537052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction.
    Daya S, Gunby J.
    Hum Reprod; 1999 Sep 24; 14(9):2207-15. PubMed ID: 10469682
    [Abstract] [Full Text] [Related]

  • 11. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles.
    van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, Al-Inany HG.
    Cochrane Database Syst Rev; 2011 Feb 16; 2011(2):CD005354. PubMed ID: 21328276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F.
    Cochrane Database Syst Rev; 2003 Feb 16; (1):CD003973. PubMed ID: 12535497
    [Abstract] [Full Text] [Related]

  • 14. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
    Ngwenya O, Lensen SF, Vail A, Mol BWJ, Broekmans FJ, Wilkinson J.
    Cochrane Database Syst Rev; 2024 Jan 04; 1(1):CD012693. PubMed ID: 38174816
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May 04; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 17. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS, Nahuis M, Bayram N, Mol BW, Van der Veen F, van Wely M.
    Cochrane Database Syst Rev; 2015 Sep 09; (9):CD010290. PubMed ID: 26350625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.
    J Reprod Med; 2004 Sep 09; 49(9):733-8. PubMed ID: 15493565
    [Abstract] [Full Text] [Related]

  • 20. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
    Youssef MA, Abou-Setta AM, Lam WS.
    Cochrane Database Syst Rev; 2016 Apr 23; 4(4):CD003719. PubMed ID: 27106604
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.